Status:
COMPLETED
Topical Vitamin C for Treatment of Basal Cell Cancer
Lead Sponsor:
Center for Biomedical Research, Inc.
Conditions:
Basal Cell Carcinoma
Eligibility:
All Genders
18-80 years
Phase:
EARLY_PHASE1
Brief Summary
Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carc...
Detailed Description
Importance Skin cancer is the most common cancer in the United States, with more people diagnosed each year than all other cancers combined (1). Basal cell cancer is the most common form with an esti...
Eligibility Criteria
Inclusion
- Presence of biopsy proven basal cell carcinoma
Exclusion
- Absence of basal cell carcinoma
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04279535
Start Date
March 1 2018
End Date
June 1 2019
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Biomedical Research,Inc.
Boise, Idaho, United States, 83706